Clinical Trial

Gene Expression Changes In Young and Geriatric Skin

Recruiting Early Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated February 6, 2025 (before its estimated December 2025 completion). Its status may not reflect the trial's current state.
Summary
This study does not involve any particular diagnosis. The goal of this research study is to explore the effects of artificial sunlight (ultraviolet B radiation; UVB) on the skin of young adults versus geriatric adults. Sunlight exerts many effects on the body. There is evidence that in response to ultraviolet B radiation (UVB), which are the burning rays of sunlight, young adult skin responds differently than geriatric skin. In fact, researchers feel that this difference in how the skin reacts to UVB is why skin cancers are found in older skin. Researchers believe that a major difference between young adult and geriatric skin is that young skin has a lot of a protein called insulin-like growth factor-1 (IGF-1), whereas geriatric skin has very little. The current study will test how young adult versus geriatric skin responds to UVB, and if geriatric skin treated with an injection of small amount of IGF-1 drug will then act like young skin.
Protocol Amendment History 11 amendments
This ClinicalTrials.gov record has been amended 11 times since 2019-04-26; most recent amendment 2025-02-05.
Status change: Not Yet Recruiting → Recruiting 2019-09-12
Trial Details
NCT Number NCT03932162
Lead Sponsor Wright State University
Conditions UVB Phototherapy Burn, Insulin-like Growth Factor 1, Aging
Enrollment 24 participants
Start Date 2019-09-06
Primary Completion 2025-12 (estimated)
Study Completion 2025-12 (estimated)
Updated on ClinicalTrials.gov 2025-02-06